Atlas Trials

Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy

Clinical trial NCT00666263 · COMPLETED

Trial details

NCT number
NCT00666263
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multifocal Motor Neuropathy
Start date
2008-08-22
Primary completion
2011-08-11
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.